Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:DAWN NASDAQ:FLYW On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeDAWNDay One Biopharmaceuticals$7.32-1.7%$7.01$5.64▼$16.76$749.28M-1.261.35 million shs444,308 shsFLYWFlywire$12.61-2.5%$12.80$8.20▼$23.40$1.54B1.292.45 million shs493,570 shsBeginner's Guide To Retirement StocksEnter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceDAWNDay One Biopharmaceuticals-1.59%+0.13%+0.40%+9.57%-47.05%FLYWFlywire-0.77%-4.86%-1.07%+16.07%-19.44%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeDAWNDay One Biopharmaceuticals$7.32-1.7%$7.01$5.64▼$16.76$749.28M-1.261.35 million shs444,308 shsFLYWFlywire$12.61-2.5%$12.80$8.20▼$23.40$1.54B1.292.45 million shs493,570 shsBeginner's Guide To Retirement StocksEnter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceDAWNDay One Biopharmaceuticals-1.59%+0.13%+0.40%+9.57%-47.05%FLYWFlywire-0.77%-4.86%-1.07%+16.07%-19.44%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceDAWNDay One Biopharmaceuticals 2.89Moderate Buy$25.29245.67% UpsideFLYWFlywire 2.19Hold$13.547.41% UpsideCurrent Analyst Ratings BreakdownLatest FLYW and DAWN Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails10/8/2025DAWNDay One BiopharmaceuticalsWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)10/8/2025FLYWFlywireWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D)9/27/2025DAWNDay One BiopharmaceuticalsWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)9/27/2025FLYWFlywireWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D)9/22/2025FLYWFlywireStephensSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingEqual Weight$13.008/18/2025DAWNDay One BiopharmaceuticalsPiper SandlerSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageOverweight$25.008/6/2025DAWNDay One BiopharmaceuticalsNeedham & Company LLCSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$18.00 ➝ $16.008/6/2025DAWNDay One BiopharmaceuticalsHC WainwrightSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$36.00 ➝ $25.008/6/2025FLYWFlywireUBS GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetNeutral$11.50 ➝ $13.507/17/2025FLYWFlywireTruist FinancialSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$12.00 ➝ $13.007/17/2025FLYWFlywireDeutsche Bank AktiengesellschaftSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageHold$12.00(Data available from 10/10/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookDAWNDay One Biopharmaceuticals$131.16M5.71N/AN/A$4.99 per share1.47FLYWFlywire$492.14M3.13$0.17 per share76.12$6.57 per share1.92Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateDAWNDay One Biopharmaceuticals-$95.50M-$0.95N/AN/AN/A-50.63%-19.01%-16.99%10/29/2025 (Estimated)FLYWFlywire$2.90M$0.05252.6050.432.751.27%1.94%1.38%11/6/2025 (Estimated)Latest FLYW and DAWN EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails11/6/2025Q3 2025FLYWFlywire$0.19N/AN/AN/A$180.07 millionN/A10/29/2025Q3 2025DAWNDay One Biopharmaceuticals-$0.28N/AN/AN/A$38.20 millionN/A8/5/2025Q2 2025DAWNDay One Biopharmaceuticals-$0.35-$0.29+$0.06-$0.29$35.55 million$33.91 million8/5/2025Q2 2025FLYWFlywire-$0.07-$0.09-$0.02-$0.10$119.65 million$127.50 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthDAWNDay One BiopharmaceuticalsN/AN/AN/AN/AN/AFLYWFlywireN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioDAWNDay One BiopharmaceuticalsN/A9.659.53FLYWFlywire0.081.871.87Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipDAWNDay One Biopharmaceuticals87.95%FLYWFlywire95.90%Insider OwnershipCompanyInsider OwnershipDAWNDay One Biopharmaceuticals6.20%FLYWFlywire4.40%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableDAWNDay One Biopharmaceuticals60102.43 million96.08 millionOptionableFLYWFlywire1,250122.31 million116.93 millionOptionableFLYW and DAWN HeadlinesRecent News About These CompaniesFlywire (FLYW): Exploring Valuation as New Quasar Partnership Boosts Global Luxury Travel Ambitions5 hours ago | finance.yahoo.comFlywire's (FLYW) Sell (D) Rating Reiterated at Weiss RatingsOctober 9 at 2:47 AM | marketbeat.comHow Investors Are Reacting To Flywire (FLYW) Becoming Quasar Expeditions' Exclusive Payments PartnerOctober 7 at 10:30 PM | finance.yahoo.comFlywire Corporation $FLYW is ABS Direct Equity Fund LLC's 4th Largest PositionSeptember 27, 2025 | marketbeat.comFLYW LAWSUIT ALERT: Levi & Korsinsky Notifies Flywire Corporation Investors of a Class Action Lawsuit and Upcoming DeadlineSeptember 25, 2025 | globenewswire.comShareholders of Flywire Corporation Should Contact The Gross Law Firm Before September 23, 2025 to Discuss Your Rights - FLYWSeptember 25, 2025 | prnewswire.comCounterpoint Mutual Funds LLC Takes Position in Flywire Corporation $FLYWSeptember 25, 2025 | marketbeat.comFlywire selected as exclusive payments partner for Quasar ExpeditionsSeptember 24, 2025 | msn.comFlywire Partners with Quasar Expeditions to Optimize Payment Solutions for Luxury Travel ExperiencesSeptember 24, 2025 | quiverquant.comQQuasar Expeditions, an Award-winning Luxury Ocean Cruise Operator, Selects Flywire as Exclusive Payments ProviderSeptember 24, 2025 | globenewswire.comFINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of FlywireSeptember 23, 2025 | businesswire.comFLYWIRE (FLYW) FINAL DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Flywire Corporation and Encourages Investors to Contact the FirmSeptember 23, 2025 | globenewswire.comPomerantz Law Firm Announces the Filing of a Class Action Against Flywire Corporation and Certain Officers - FLYWSeptember 23, 2025 | prnewswire.comFlywire Deadline Today: Rosen Law Firm Urges Flywire Corporation (NASDAQ: FLYW) Stockholders with Large Losses to Contact the Firm for Information About Their RightsSeptember 23, 2025 | businesswire.comFLYW DEADLINE ALERT: ROSEN, A LEADING NATIONAL FIRM, Encourages Flywire Corporation Investors to Secure Counsel Before Important September 23 Deadline in Securities Class Action – FLYWSeptember 22, 2025 | globenewswire.comLevi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of September 23, 2025 in Flywire Corporation Lawsuit – FLYWSeptember 22, 2025 | globenewswire.com4 Analysts Assess Flywire: What You Need To KnowSeptember 22, 2025 | benzinga.comDeadline Soon: Flywire Corporation (FLYW) Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud LawsuitSeptember 22, 2025 | businesswire.comFlywire's (FLYW) "Equal Weight" Rating Reaffirmed at StephensSeptember 22, 2025 | marketbeat.comInvestors who lost money on Flywire Corporation(FLYW) should contact The Gross Law Firm about pending Class Action - FLYWSeptember 22, 2025 | prnewswire.comFLYW Investors Have Opportunity to Lead Flywire Corporation Securities Fraud LawsuitSeptember 22, 2025 | prnewswire.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeFLYW and DAWN Company DescriptionsDay One Biopharmaceuticals NASDAQ:DAWN$7.32 -0.13 (-1.68%) As of 01:06 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genomically defined cancers. Its lead product candidate is tovorafenib, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric patients with relapsed/ refractory low-grade glioma. The company is also developing Pimasertib, an oral small molecule inhibitor of mitogen-activated protein kinase kinases 1 and 2. Day One Biopharmaceuticals, Inc. was incorporated in 2018 and is headquartered in Brisbane, California.Flywire NASDAQ:FLYW$12.61 -0.32 (-2.50%) As of 01:06 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.Flywire Corporation, together with its subsidiaries, operates as a payments enablement and software company in the United States and internationally. Its payment platform and network, and vertical-specific software help clients to get paid and help their customers to pay. The company's platform facilitates payment flows across multiple currencies, payment types, and payment options, as well as provides direct connections to alternative payment methods, such as Alipay, Boleto, PayPal/Venmo, and Trustly. It serves education, healthcare, travel, and business to business organizations. The company was formerly known as peerTransfer Corporation and changed its name to Flywire Corporation in December 2016. Flywire Corporation was incorporated in 2009 and is headquartered in Boston, Massachusetts. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Why Amazon’s Prime Day May Be the Catalyst for a Year-End Rally How Gamers Are Powering Microsoft’s Next Wave of Growth AI Meets Nuclear: Palantir’s Role in Energy Expansion Buy the Dip? Zillow’s Profit Comeback Meets Market Pressure Adobe Launches Premiere Pro on iPhone, Upside Ahead? Rocket Lab: A Space Giant Hitting New Highs—Time to Chase? After AI Hyperscaler Deal, Is Aehr Test Systems Stock on Sale? Why Archer Aviation Stock Is Soaring—And What Comes Next Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
